Partnership Immuno-oncology and onco-pediatrics: Institut Curie and Bristol-Myers Squibb become partners 09/22/2016
logo institut carnot curie cancer web Innovation The label Institut Carnot Curie Cancer of Institut Curie renewed 07/25/2016
Partnership New agreement signed with IBA: Proton Therapy at Institut Curie expands research capabilities with a new experimental line 07/01/2016
DNA Thearpeutics was acquired in 2016 by ONXEO. First-in-class, signal-interfering DNA molecule based on one of the most promising new approaches in cancer treatment www.onxeo.com Innovation The DBAIT success story 03/02/2016
DNA Thearpeutics was acquired in 2016 by ONXEO. First-in-class, signal-interfering DNA molecule based on one of the most promising new approaches in cancer treatment www.onxeo.com
Partnership Microbrain Biotech signs an exclusive license to develop neuronal screening with Institut Curie, CNRS and UPMC 02/11/2016